| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $190K | -19.1% |
| R&D Expense | $60.2M | +10.8% |
| SG&A Expense | $17.6M | +27.7% |
| Operating Income | -$77.6M | -14.3% |
| Pre-tax Income | -$74.1M | -15.8% |
| Income Tax | $0 | — |
| Net Income | -$74.1M | -15.8% |
| EPS (Basic) | -$0.80 | +7.0% |
| EPS (Diluted) | -$0.80 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | -2.8% |
| Current Assets | $80.2M | -2.1% |
| Total Assets | $93.0M | -4.0% |
| Current Liabilities | $15.1M | +1.2% |
| Stockholders' Equity | $67.5M | -3.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.0M | +10.3% |
| Capital Expenditures | $77K | +18.5% |
| Investing Cash Flow | -$5.1M | -129.3% |
| Financing Cash Flow | $66.0M | +65.6% |
| Free Cash Flow | -$62.1M | +10.3% |
| +7.0% |